Tripuraneni Radhika has filed 16 insider transactions across 2 companies since June 2023.
Most recent transaction: a disposition of 1697 shares of Terns Pharmaceuticals, Inc. ($TERN) on May 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 1697 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.00% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 64000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.07% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 32000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.03% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 32000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.03% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 4676 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.01% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 10657 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.01% |
| May 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.05% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tripuraneni Radhika | Chief Medical Officer | A | Restricted Stock Units | 19150 | $0.00 | 19,150.0000 | 95,442,008 | 9999.99% | 0.02% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Tripuraneni Radhika | Chief Medical Officer | A | Stock Option (Right to Buy) | 95800 | $0.00 | 95,800.0000 | 95,442,008 | 9999.99% | 0.10% |
| Feb. 1, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| June 11, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| March 10, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Tripuraneni Radhika | Chief Medical Officer | A | Stock Option (Right to Buy) | 310700 | $0.00 | 310,700.0000 | 81,484,950 | 9999.99% | 0.38% |
| Feb. 1, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| July 1, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| June 10, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 12, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |